Evidence map›Paper›PMID 41586262›Full record

ArticleStroke (Hoboken, N.J.)2022

Immediate Recanalization of Large-Vessel Occlusions by Tissue Plasminogen Activator Occurs in 28% of Patients Treated in a Mobile Stroke Unit.

Alexandra L Czap, Stephanie Parker, Jose-Miguel Yamal, Mengxi Wang, Noopur Singh, Jinhao Zou, Kenny Phan, Suja S Rajan, James C Grotta, Ritvij Bowry

Abstract read
In one paragraph

Article in Stroke (Hoboken, N.J.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. "Chopperlysis": The effect of helicopter transport on reperfusion and outcomes in large vessel occlusion strokes.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2024
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Alexandra L CzapDepartment of Neurology McGovern Medical School at the University of Texas Health Science Center at Houston TX.ORCID https://orcid.org/0000-0002-9151-6015
Stephanie ParkerDepartment of Neurology McGovern Medical School at the University of Texas Health Science Center at Houston TX.
Jose-Miguel YamalDepartment of Biostatistics and Data Science School of Public Health at the University of Texas Health Science Center at Houston TX.
Mengxi WangDepartment of Biostatistics and Data Science School of Public Health at the University of Texas Health Science Center at Houston TX.
Noopur SinghDepartment of Biostatistics and Data Science School of Public Health at the University of Texas Health Science Center at Houston TX.
Jinhao ZouDepartment of Biostatistics and Data Science School of Public Health at the University of Texas Health Science Center at Houston TX.
Kenny PhanDepartment of Neurology McGovern Medical School at the University of Texas Health Science Center at Houston TX.
Suja S RajanDepartment of Management Policy and Community Health School of Public Health at the University of Texas Health Science Center at Houston TX.
James C GrottaMobile Stroke Unit and Stroke Research Clinical Innovation and Research Institute at the Memorial Hermann Hospital TX.
Ritvij BowryDepartment of Neurology McGovern Medical School at the University of Texas Health Science Center at Houston TX.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Recanalization of cerebral large-vessel occlusions (LVOs) by intravenous thrombolysis is infrequent but has been relatively unexplored with ultraearly treatment. We evaluated prehospital treatment with tissue plasminogen activator (tPA) in a mobile stroke unit to explore the recanalization rate in patients with LVOs and its effect on early clinical improvement and long-term disability. Methods: Prospectively collected data were analyzed from Houston mobile stroke unit patients who were treated with tPA and had LVOs identified by either hyperdense arteries on computed tomography or arterial occlusion on computed tomography angiography while on board the mobile stroke unit. The primary outcome was immediate recanalization (IRC), categorized as resolution of LVO on repeat vascular imaging in the emergency department (ED) or on emergent angiography. The secondary outcome was change in National Institutes of Health Stroke Scale from baseline and modified Rankin score at 90 days. Results: Sixty-nine patients with anterior or posterior circulation LVOs were enrolled; the median time from last known normal to tPA bolus was 64.0 minutes (interquartile range, 52.0-89.0). Nineteen patients (28%) had IRC, with 11 based on computed tomography angiography on ED arrival and 8 based on first run of emergent angiography. Median time from tPA bolus to documentation of IRC was 61.0 minutes (interquartile range, 42.0-111.0). IRC was associated with improvement in median National Institutes of Health Stroke Scale from baseline (17.0 [14.0-22.0]) to ED arrival (10.0 [5.5-16.5]) and to 24 hours (4.0 [0.5-10.5]). Of the non-IRC patients, 41 had recanalization after endovascular thrombectomy and 9 did not receive recanalization. The IRC group, earlier last known normal to tPA bolus, greater baseline National Institutes of Health Stroke Scale, and M1 and M2 middle cerebral artery occlusion locations were independently associated with greater improvement in National Institutes of Health Stroke Scale from baseline to ED arrival. The 90-day modified Rankin score distribution was best in the IRC group, followed by the delayed recanalization group, and both had significantly less disability than the no recanalization group ( Conclusions: Recanalization by ED arrival occured in 28% of patients with LVO who received tPA treatment in a mobile stroke unit and results in early clinical improvement and less disability at 90 days.

Indexed as

emergency medical serviceslarge‐vessel occlusionmobile stroke unitprehospitalrecanalizationstrokethrombolysis

Identifiers

PMID41586262
PMCPMC12778757

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.